ImmuPharma (IMM.L) – BUY*: Update on Phase 3 trial | Savannah Resources (SAV.L) – CORP: Finland update | Amphion Innovations plc (AMP.L) – CORP: Interims | Starcom (STAR.L) – BUY*: H116 Results
07 Sep 2016
Northland Capital Partners Morning Report
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Northland Capital Partners Morning Report
ImmuPharma plc (IMM:LON), 2.2 | Amphion Innovations (AMP:LON), 0 | Savannah Resources Plc (SAV:LON), 3.3 | t42 IoT Tracking Solutions PLC (TRAC:LON), 3.0
- Published:
07 Sep 2016 -
Author:
Vadim Alexandre -
Pages:
6
ImmuPharma (IMM.L) – BUY*: Update on Phase 3 trial | Savannah Resources (SAV.L) – CORP: Finland update | Amphion Innovations plc (AMP.L) – CORP: Interims | Starcom (STAR.L) – BUY*: H116 Results